Twist2 promotes kidney cancer cell proliferation and invasion by regulating iTga6 and cD44 expression in the ecM-receptor interaction pathway

: Twist2 is a member of the basic helix-loop-helix (bHLH) family and plays a critical role in tumorigenesis. Growing evidence has proven that Twist2 is involved in tumor progression; however, the role of Twist2 in human kidney cancer and its underlying mechanisms remain unclear. Real-time polymerase chain reaction and Western blot analysis were used to detect the expression of Twist2 in kidney cancer cells and tissues. Cell proliferation, cell cycle, apoptosis, migration, and invasion assay were analyzed using the Cell Count Kit-8, flow cytometry, wound healing, and Transwell analysis, respectively. In this study, we showed that Twist2 was upregulated in human kidney cancer tissues compared with normal kidney tissues. Twist2 promoted cell proliferation, inhibited cell apoptosis, and augmented cell migration and invasion in human kidney-cancer-derived cells in vitro. Twist2 also promoted tumor growth in vivo. Moreover, we found that the knockdown of Twist2 decreased the levels of ITGA6 and CD44 expression. This result indicates that Twist2 may promote migration and invasion of kidney cancer cells by regulating ITGA6 and CD44 expression. Therefore, our data demonstrated that Twist2 is involved in kidney cancer progression. The identification of the role of Twist2 in the migration and invasion of kidney cancer provides a potential appropriate treatment for human kidney cancer.

[1]  Xin Hu,et al.  Twist2 promotes kidney cancer cell proliferation and invasion by regulating ITGA6 and CD44 expression in the ECM-receptor interaction pathway , 2016, OncoTargets and therapy.

[2]  Jie Xu,et al.  Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer. , 2014, Cancer research.

[3]  K. Ohba,et al.  High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma. , 2014, International journal of clinical and experimental pathology.

[4]  Shuyong Lin,et al.  Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24. , 2014, Carcinogenesis.

[5]  A. R. D. de Vasconcelos,et al.  ITGA6 gene silencing by RNA interference modulates the expression of a large number of cell migration-related genes in human thymic epithelial cells , 2013, BMC Genomics.

[6]  K. Harada,et al.  Expression of epithelial–mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy , 2012, BJU international.

[7]  S. Piña‐Oviedo,et al.  Synchronous clear cell renal cell carcinoma and tubulocystic carcinoma: genetic evidence of independent ontogenesis and implications of chromosomal imbalances in tumor progression , 2012, Diagnostic Pathology.

[8]  Yi-Wen Chang,et al.  Direct reprogramming of stem cell properties in colon cancer cells by CD44 , 2011, The EMBO journal.

[9]  Chonghui Cheng,et al.  CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. , 2011, The Journal of clinical investigation.

[10]  James W. Tung,et al.  Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties , 2010, PloS one.

[11]  C. Cadilla,et al.  Redundant or separate entities?—roles of Twist1 and Twist2 as molecular switches during gene transcription , 2010, Nucleic acids research.

[12]  A. Puisieux,et al.  TWISTing an embryonic transcription factor into an oncoprotein , 2010, Oncogene.

[13]  L. Truong,et al.  Virtual-Karyotyping With SNP Microarrays in Morphologically Challenging Renal Cell Neoplasms: A Practical and Useful Diagnostic Modality , 2009, The American journal of surgical pathology.

[14]  E. Wallen,et al.  Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma , 2009, Oncogene.

[15]  Yi Tie,et al.  miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. , 2009, Cancer letters.

[16]  Börje Ljungberg,et al.  Tensin3 Is a Negative Regulator of Cell Migration and All Four Tensin Family Members Are Downregulated in Human Kidney Cancer , 2009, PloS one.

[17]  R. Maestro,et al.  Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. , 2008, Cancer cell.

[18]  D. Virshup,et al.  Wnt signaling in development, disease and translational medicine. , 2008, Current drug targets.

[19]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[20]  T. Brabletz,et al.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells , 2008, EMBO reports.

[21]  G. Wagner,et al.  Scleraxis and NFATc Regulate the Expression of the Pro-α1(I) Collagen Gene in Tendon Fibroblasts* , 2007, Journal of Biological Chemistry.

[22]  J. Shay,et al.  BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.

[23]  V. Centonze,et al.  Altered Twist1 and Hand2 dimerization is associated with Saethre-Chotzen syndrome and limb abnormalities , 2005, Nature Genetics.

[24]  Yoshikazu Johmura,et al.  The novel gene fad104, containing a fibronectin type III domain, has a significant role in adipogenesis , 2004, FEBS letters.

[25]  J. Wilson-Rawls,et al.  Paraxis Is a Basic Helix-Loop-Helix Protein That Positively Regulates Transcription through Binding to Specific E-box Elements* , 2004, Journal of Biological Chemistry.

[26]  D. Sassoon.  Faculty Opinions recommendation of Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. , 2003 .

[27]  A. Nakagawara,et al.  Trk receptor tyrosine kinases: a bridge between cancer and neural development. , 2001, Cancer letters.

[28]  A. Firulli,et al.  The Basic Helix-Loop-Helix Transcription factorsdHAND and eHAND Exhibit Dimerization Characteristics That Suggest Complex Regulation of Function* , 2000, The Journal of Biological Chemistry.

[29]  C. Glackin,et al.  TWIST, a basic helix‐loop‐helix transcription factor, can regulate the human osteogenic lineage , 1999, Journal of cellular biochemistry.

[30]  J. Sarama,et al.  Validation of routine mycoplasma testing by PCR , 1998, In Vitro Cellular & Developmental Biology - Animal.

[31]  P. Bugert,et al.  Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis. , 1996, The American journal of pathology.

[32]  E. Füchtbauer,et al.  M-twist is an inhibitor of muscle differentiation. , 1994, Developmental biology.

[33]  S. Harrison,et al.  Crystal structure of transcription factor E47: E-box recognition by a basic region helix-loop-helix dimer. , 1994, Genes & development.

[34]  P. Gerlinger,et al.  The M-twist gene of Mus is expressed in subsets of mesodermal cells and is closely related to the Xenopus X-twi and the Drosophila twist genes. , 1991, Developmental biology.

[35]  Y. Jan,et al.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence , 1989, Cell.

[36]  Hongyan Liu,et al.  CD44 expression is predictive of poor prognosis in pharyngolaryngeal cancer: systematic review and meta-analysis. , 2014, The Tohoku journal of experimental medicine.

[37]  Tian-qi Wang,et al.  Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma. , 2012, Gynecologic oncology.

[38]  M. Tomayko,et al.  Determination of subcutaneous tumor size in athymic (nude) mice , 2004, Cancer Chemotherapy and Pharmacology.

[39]  P. Tam,et al.  Twist functions in mouse development. , 2002, The International journal of developmental biology.

[40]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.